Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125534571 | 12553457 | 1 | I | 20150604 | 20150604 | 20160713 | 20160713 | PER | US-PERRIGO-15US005765 | PERRIGO | 86.78 | YR | M | Y | 88.44000 | KG | 20160713 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125534571 | 12553457 | 1 | PS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 15 MG, SINGLE | Y | 5DE1492 | 202319 | 15 | MG | MODIFIED-RELEASE CAPSULE, HARD | ||||||
125534571 | 12553457 | 2 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, UNKNOWN | U | UNKNOWN | 0 | ||||||||
125534571 | 12553457 | 3 | C | DIFLUNISAL. | DIFLUNISAL | 1 | Unknown | UNK | U | UNKNOWN | 0 | ||||||||
125534571 | 12553457 | 4 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | 20 MG | U | UNKNOWN | 0 | ||||||||
125534571 | 12553457 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 5 MG | U | UNKNOWN | 0 | ||||||||
125534571 | 12553457 | 6 | C | TAMSULOSIN | TAMSULOSIN | 1 | Unknown | 0.4 MG | U | UNKNOWN | 0 | ||||||||
125534571 | 12553457 | 7 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | UNK | U | UNKNOWN | 0 | ||||||||
125534571 | 12553457 | 8 | C | TEKTURNA | ALISKIREN HEMIFUMARATE | 1 | Unknown | 75 MG | U | UNKNOWN | 0 | ||||||||
125534571 | 12553457 | 9 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | 12.5 MG, BID | U | UNKNOWN | 0 | 12.5 | MG | ||||||
125534571 | 12553457 | 10 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 40 MG | U | UNKNOWN | 0 | ||||||||
125534571 | 12553457 | 11 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | 300 MG | U | UNKNOWN | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125534571 | 12553457 | 1 | Gastrooesophageal reflux disease |
125534571 | 12553457 | 2 | Supplementation therapy |
125534571 | 12553457 | 3 | Arthritis |
125534571 | 12553457 | 4 | Hypertension |
125534571 | 12553457 | 5 | Hypertension |
125534571 | 12553457 | 6 | Prostatomegaly |
125534571 | 12553457 | 7 | Anticoagulant therapy |
125534571 | 12553457 | 8 | Hypertension |
125534571 | 12553457 | 9 | Hypertension |
125534571 | 12553457 | 10 | Hypertension |
125534571 | 12553457 | 11 | Gout |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125534571 | 12553457 | Diarrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125534571 | 12553457 | 1 | 20150604 | 20150604 | 0 |